| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-12 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-11 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-11 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-11 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-10 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-10 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-10 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-09 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |